| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/20/1998 | CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders |
| 05/20/1998 | CN1182349A Long ter storage of red cells in unfrozen solution |
| 05/20/1998 | CN1182126A Drug abstaining wine |
| 05/20/1998 | CN1181968A Hypoglycemic medicine composition |
| 05/20/1998 | CN1181967A Shengguipeiyuan medicine granule for curing serious amyasthenia and its preparation |
| 05/20/1998 | CN1181947A Clystering liquid for curing lupus colonitis |
| 05/20/1998 | CN1181944A Drug-abstaining oral liquid and its preparation |
| 05/20/1998 | CN1181941A Wulong injection |
| 05/20/1998 | CN1181937A Production process of medicated royal jelly |
| 05/20/1998 | CN1038389C Medicine |
| 05/19/1998 | US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them |
| 05/19/1998 | US5753703 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 05/19/1998 | US5753631 Intercellular adhesion mediators |
| 05/19/1998 | US5753506 Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
| 05/19/1998 | US5753505 Genetic expressing a marker, cell differentiation for treating nervous system disorder, alzheimer's disease |
| 05/19/1998 | US5753499 Viral vector complexes having adapters of predefined valence |
| 05/19/1998 | US5753491 Use of neuro-derived fetal cell lines for transplantation therapy |
| 05/19/1998 | US5753485 Purified mixture of collagenase I, collagenase II and two other proteases |
| 05/19/1998 | US5753479 Genetic enginnering |
| 05/19/1998 | US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression |
| 05/19/1998 | US5753428 Synthetic composition for storage of platelets comprising glycerol |
| 05/19/1998 | US5753427 General method to quickly add cryoprotectants to animal cells while maintaining viability |
| 05/19/1998 | US5753268 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 05/19/1998 | US5753221 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
| 05/19/1998 | CA1339873C Recombinant colony stimulating factor-1 |
| 05/14/1998 | WO1998020146A2 Stabilized transient gene expression |
| 05/14/1998 | WO1998019722A1 Method for purifying blood plasma and apparatus suitable therefor |
| 05/14/1998 | WO1998019719A1 Myocardial graft constructs |
| 05/14/1998 | WO1998019712A1 Methods for regulating angiogenesis |
| 05/14/1998 | WO1998019695A1 Device and method for delivery of erythropoietin |
| 05/14/1998 | WO1998019688A1 Pharmaceutical composition for treatment of diabetes |
| 05/14/1998 | WO1998019541A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
| 05/14/1998 | WO1998019540A1 In vivo selection of primitive hematopoietic cells |
| 05/14/1998 | WO1998010102A3 Multi-resistant bacteria, methods for obtaining them and their uses |
| 05/14/1998 | WO1998010085A3 Gene therapy for congestive heart failure |
| 05/14/1998 | WO1998009637A3 Treatment of diabetes |
| 05/14/1998 | CA2271203A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
| 05/14/1998 | CA2270413A1 Method for purifying blood plasma and apparatus suitable therefor |
| 05/14/1998 | CA2270137A1 Stabilized transient gene expression |
| 05/13/1998 | EP0841396A1 Human telomerase catalytic subunit |
| 05/13/1998 | EP0841392A2 Attenuated live neospora vaccine |
| 05/13/1998 | EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 05/13/1998 | EP0841010A1 Stable compositions dispersible in cold water |
| 05/13/1998 | EP0840797A1 Methods and means for targeted gene delivery |
| 05/13/1998 | EP0840781A1 Methods and devices for the removal of psoralens from blood products |
| 05/13/1998 | EP0840624A1 Method and apparatus for inactivating contaminants in blood products |
| 05/13/1998 | EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 05/13/1998 | EP0840618A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies |
| 05/13/1998 | EP0688223A4 -i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS |
| 05/13/1998 | CN1181691A Oral compsn. for animals |
| 05/13/1998 | CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor |
| 05/13/1998 | CN1181264A Zaohuang paste and treating burns and its prepn. |
| 05/13/1998 | CN1181262A Preparation for treating burns and empyrosis and its preparing process |
| 05/13/1998 | CN1181259A Powder for eliminating infantile malnutrition of child and its prepn. method |
| 05/13/1998 | CN1181258A Traumatic paraplegia pills or capsules |
| 05/13/1998 | CN1181244A Health oral liquid |
| 05/13/1998 | CN1181243A Cauma spray agent and its prodn. method |
| 05/13/1998 | CN1181242A Micro fetus active composite, its preparing process and application in cosmetics |
| 05/13/1998 | CN1181238A preparations |
| 05/13/1998 | CN1181180A Fresh bee chrysalis and prodn. method of its various kinds of preparation |
| 05/13/1998 | CN1038305C Softening process for pilose antler slice |
| 05/12/1998 | US5750867 Maintenance of male-sterile plants |
| 05/12/1998 | US5750658 Fibrinogen processing apparatus, method and container |
| 05/12/1998 | US5750657 Methods and compositions using fibrin monomer to make a fibrin sealant |
| 05/12/1998 | US5750398 Vector, element and method for inhibiting immune recognition |
| 05/12/1998 | US5750397 Human hematopoietic stem cell |
| 05/12/1998 | US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus |
| 05/12/1998 | US5750376 In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| 05/12/1998 | US5750366 Cloning and expression of gonadotropin-releasing hormone receptor |
| 05/12/1998 | US5750176 Transgenic non-human mammal milk comprising 2'-fucosyl-lactose |
| 05/12/1998 | US5750149 Applying to skin |
| 05/12/1998 | US5750144 Oral administration of subdivided and sterilized, undenatured water-insoluble type ii collagen extracted from animal cartilage |
| 05/12/1998 | US5750103 Method for transplanting cells into the brain and therapeutic uses therefor |
| 05/12/1998 | US5750039 Blood processing systems and methods for collecting mono nuclear cells |
| 05/07/1998 | WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 05/07/1998 | WO1998018934A1 Therapeutic gene |
| 05/07/1998 | WO1998018926A1 Circularly permuted erythropoietin receptor agonists |
| 05/07/1998 | WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS |
| 05/07/1998 | WO1998018921A1 NEUTROKINE $g(a) |
| 05/07/1998 | WO1998018908A1 Systems and methods for removing viral agents from blood |
| 05/07/1998 | WO1998018907A1 Process for producing tumoricide t-lymphocytes |
| 05/07/1998 | WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses |
| 05/07/1998 | WO1998018809A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | WO1998018478A1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 05/07/1998 | WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 05/07/1998 | WO1998006746A3 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 05/07/1998 | WO1998006411A3 Use of lactobacillus gg in the rehydrating solution |
| 05/07/1998 | WO1997046683A3 Polynucleotides encoding secreted proteins |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2270117A1 Process for producing tumoricide t-lymphocytes |
| 05/07/1998 | CA2269738A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | CA2268027A1 Novel flt-3 receptor agonists |
| 05/07/1998 | CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | CA2268001A1 Circularly permuted erythropoietin receptor agonists |
| 05/06/1998 | EP0839535A1 An extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo |
| 05/06/1998 | EP0839199A1 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
| 05/06/1998 | EP0839195A1 Nucleotide and peptide sequences for treating myasthenia |
| 05/06/1998 | EP0839194A1 Protein p53 variants and their therapeutic uses |